| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From Methodist Healthcare, Memphis, TN.
Correspondence to: Grant W. Waterer, MBBS, Pulmonary Host Defense Fellow, Methodist Healthcare, 1265 Union Ave, 501 Crews Wing, Memphis, TN 38104-2499; e-mail: waterer{at}ibm.net
Introduction: The cost-effectiveness of blood cultures in community-acquired pneumonia (CAP) has been questioned. Although penicillin-resistant Streptococcus pneumoniae is an increasing problem, penicillin therapy, where appropriate, reduces cost and may reduce antibiotic resistance. Blood cultures, however, can only reduce cost if physicians are prepared to alter therapy based on the results. We reviewed our experience to determine how often physicians changed management based on blood culture results positive for S pneumoniae.
Methods: Retrospective chart review was performed of all CAP admissions between January 1996 and December 1998 with blood culture results positive for S pneumoniae.
Results: Seventy-four patients out of 1,805 patients admitted with CAP during this period had pneumococcemia. Penicillin resistance was identified in 15 cases (20.3%; high grade in 4 cases) with cephalosporin resistance in 4 of these cases (1 high grade). Fifty-one patients had initial empiric therapy with a third-generation cephalosporin, and 58 patients had empiric coverage of atypical organisms; no patient received empiric penicillin therapy. Blood culture results altered management in 31 patients (41.9%), but in only 2 cases was this due to antibiotic resistance. Fifty-one patients without penicillin allergy grew penicillin-sensitive pneumococci; only 11 patients (21.6%) were changed to penicillin therapy. Thirteen of 35 patients (37.1%) who were given an additional antibiotic for atypical coverage had this antibiotic ceased.
Conclusion: Despite evidence of penicillin-sensitive pneumococcal CAP, physicians were reluctant to narrow antibiotic therapy, potentially adding to treatment cost and reducing the impact of blood culture results on management. The impact of penicillin resistance was reduced by the usual empiric choice of a third-generation cephalosporin. While positive blood culture results can clearly be useful in the management of patients with CAP, their cost-effectiveness needs to be assessed in prospective clinical trials.
Key Words: antibiotics • bacteremia • community-acquired • penicillin • pneumonia
This article has been cited by other articles:
|
|
 |
|
  The CMS Blood Cultures for CAP Program: The Architects Speak Out Journal Watch Emergency Medicine, April 27, 2005; 2005(427): 1 - 1. [Full Text]
|
|
|
|
 |
|
 J Corbo, B Friedman, P Bijur, and E J Gallagher Limited usefulness of initial blood cultures in community acquired pneumonia Emerg. Med. J., July 1, 2004; 21(4): 446 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Craven Blood Cultures for Community-Acquired Pneumonia: Piecing Together a Mosaic for Doing Less Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 327 - 328. [Full Text] [PDF]
|
|
|
|
|
|
M. L. Metersky, A. Ma, D. W. Bratzler, and P. M. Houck Predicting Bacteremia in Patients with Community-Acquired Pneumonia Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 342 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Oosterheert, M. J. M. Bonten, E. Buskens, M. M. E. Schneider, and I. M. Hoepelman Algorithm To Determine Cost Savings of Targeting Antimicrobial Therapy Based on Results of Rapid Diagnostic Testing J. Clin. Microbiol., October 1, 2003; 41(10): 4708 - 4713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Cregin Current Management Issues Associated with Community-Acquired Pneumonia Journal of Pharmacy Practice, October 1, 2003; 16(5): 324 - 334. [Abstract] [PDF]
|
|
|
|
 |
|
 S. G. Campbell, T. J. Marrie, R. Anstey, G. Dickinson, and S. Ackroyd-Stolarz The Contribution of Blood Cultures to the Clinical Management of Adult Patients Admitted to the Hospital With Community-Acquired Pneumonia: A Prospective Observational Study Chest, April 1, 2003; 123(4): 1142 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Wunderink and G. W. Waterer Appropriate Microbiological Testing in Community-Acquired Pneumonia Chest, January 1, 2001; 119(1): 5 - 7. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
